Glucotrack, Inc. (GCTK)
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
GlucoTrack, Inc.
OTC:GCTKOTC (suspended from Nasdaq on Oct 30, 2026)Healthcare · Medical - Devices
-1.79%$0.1870
Prev close$0.1904+10.29%Open$0.2100-10.95%Now$0.1870
Mkt Cap$221K
EV-
Float1.09M
O/S1.18M
VOL6K sh
$ Vol$1K
RVOL0.00×
Inst Own3.9%
Net Cash/Sh-
Dilution
MCap$221KFloat1.09MO/S1.18M
Dilution
Glucotrack, Inc. (GCTK) dilution facts from SEC filings
Snapshot as of Jun 30, 2026, built from 45 SEC filings.
- At-the-market (ATM) program
- No active program in the filings reviewed
- Warrants outstanding
- 20 warrant series recorded as outstanding
Check another stock for dilution
Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.